RVW Wealth’s Revolution Medicines RVMD Stock Holding History

RVW Wealth’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$245K	Hold	1,194	–	–	0.02%	168
2026 Q2	$224K	Buy	+1,194	New	+$174K	0.01%	173

Other funds holding RVMD

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Loftus Peak Sydney, Australia $781M AUM

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

RVW Wealth's RVMD Position: Q3 2026 in Review

RVW Wealth held its Revolution Medicines (RVMD) position steady in Q3 2026 at 1,194 shares worth $245K. The position accounts for 0.02% of the portfolio, ranked #168.

RVW Wealth first reported a position in RVMD in Q2 2026 and has held it in 2 quarters since. 212 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

RVW Wealth held 1,194 shares of Revolution Medicines worth $245K as of Q3 2026.
RVW Wealth left its Revolution Medicines share count unchanged in Q3 2026.
Revolution Medicines made up 0.02% of RVW Wealth's portfolio in Q3 2026, its #168 holding.
RVW Wealth first reported a position in Revolution Medicines in Q2 2026 and has held it in 2 quarters since.
212 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on RVW Wealth's 13F filing for Q3 2026, filed 6 Oct 2026.